Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
Abstract
:1. Introduction
2. Vitamin D and Its Deficiency
3. Vitamin D Deficiency Treatment
4. Mechanisms Associated with Vitamin D Status
5. Guidelines
6. Summary
Author Contributions
Conflicts of Interest
References
- Foley, R.N.; Parfrey, P.S.; Sarnak, M.I. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998, 32, S112–S119. [Google Scholar] [CrossRef] [PubMed]
- Longenecker, J.C.; Coresh, J.; Powe, N.R.; Levey, A.S.; Fink, N.E.; Martin, A.; Klag, M.J. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J. Am. Soc. Nephrol. 2002, 13, 1918–1927. [Google Scholar] [CrossRef] [PubMed]
- Levin, A.; Li, Y.C. Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005, 68, 1973–1981. [Google Scholar] [CrossRef] [PubMed]
- Fanari, Z.; Hammami, S.; Hammami, M.B.; Hammami, S.; Abdellatif, A. Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration? J. Saudi Heart Assoc. 2015, 27, 264–271. [Google Scholar] [CrossRef] [PubMed]
- Toussaint, N.D.; Damasiewicz, M.J. Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms? Nephrology 2017, 22, 51–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sprague, S.M. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2007, 72, 895. [Google Scholar] [CrossRef] [PubMed]
- Zheng, Z.; Shi, H.; Jia, J.; Li, D.; Lin, S. Vitamin D supplementation and mortality risk in chronic kidney disease: A meta-analysis of 20 observational studies. BMC Nephrol. 2013, 14, 199. [Google Scholar] [CrossRef] [PubMed]
- Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49, 1063–1069. [Google Scholar] [CrossRef] [PubMed]
- Pittas, A.G.; Dawson-Hughes, B.; Li, T.; Van Dam, R.M.; Willett, W.C.; Manson, J.E.; Hu, F.B. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29, 650–656. [Google Scholar] [CrossRef] [PubMed]
- Wolf, M.; Shah, A.; Gutierrez, O.; Ankers, E.; Monroy, M.; Tamez, H.; Steele, D.; Chang, Y.; Camargo, C.A., Jr.; Tonelli, M.; et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007, 72, 1004–1013. [Google Scholar] [CrossRef] [PubMed]
- Palmer, S.C.; McGregor, D.O.; Craig, J.C.; Elder, G.; Macaskill, P.; Strippoli, G.F. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst. Rev. 2009, 4, CD008175. [Google Scholar] [CrossRef]
- Block, G.A.; Klassen, P.S.; Lazarus, J.M.; Ofsthun, N.; Lowrie, E.G.; Chertow, G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J. Am. Soc. Nephrol. 2004, 15, 2208–2218. [Google Scholar] [CrossRef] [PubMed]
- Quarles, L.D. Endocrine functions of bone in mineral metabolism regulation. J. Clin. Investig. 2008, 118, 3820–3828. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Thadhani, R.; Appelbaum, E.; Pritchett, Y.; Chang, Y.; Wenger, J.; Tamez, H.; Bhan, I.; Agarwal, R.; Zoccali, C.; Wanner, C.; et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial. JAMA 2012, 307, 674–684. [Google Scholar] [CrossRef] [PubMed]
- Shapses, S.A.; Manson, J.E. Vitamin D and prevention of cardiovascular disease and diabetes: Why the evidence falls short. JAMA 2011, 305, 2565–2566. [Google Scholar] [CrossRef] [PubMed]
- Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Available online: http://books.nap.edu/openbook.php?record_id=13050 (accessed on 20 April 2018).
- Koenig, K.G.; Lindberg, J.S.; Zerwekh, J.E.; Padalino, P.K.; Cushner, H.M.; Copley, J.B. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int. 1992, 41, 161–165. [Google Scholar] [CrossRef] [PubMed]
- Jacob, A.I.; Sallman, A.; Santiz, Z.; Hollis, B.W. Defective photoproduction of cholecalciferol in normal and uremic humans. J. Nutr. 1984, 114, 1313–1319. [Google Scholar] [CrossRef] [PubMed]
- Melamed, M.L.; Thadhani, R.I. Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease. Clin. J. Am. Soc. Nephrol. 2012, 7, 358–365. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, M.S.; Shoker, A. Vitamin D metabolites; protective versus toxic properties: Molecular and cellular perspectives. Nephrol. Rev. 2010, 2, 19–26. [Google Scholar]
- Alshahrani, F.; Aljohani, N. Vitamin D: Deficiency, Sufficiency and Toxicity. Nutrients 2013, 5, 3605–3616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266–281. [Google Scholar] [CrossRef] [PubMed]
- Drechsler, C.; Pilz, S.; Obermayer-Pietsch, B.; Verduijn, M.; Tomaschitz, A.; Krane, V.; Espe, K.; Dekker, F.; Brandenburg, V.; März, W.; et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur. Heart J. 2010, 31, 2253–2261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peterlik, M.; Cross, H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur. J. Clin. Investig. 2005, 35, 290–304. [Google Scholar] [CrossRef] [PubMed]
- Samelson, E.J.; Kiel, D.P.; Broe, K.E.; Zhang, Y.; Cupples, L.A.; Hannan, M.T.; Wilson, P.W.; Levy, D.; Williams, S.A.; Vaccarino, V. Metacarpal cortical area and risk of coronary heart disease: The Framingham Study. Am. J. Epidemiol. 2004, 159, 589–595. [Google Scholar] [CrossRef] [PubMed]
- Contreras, J.J.; Hiestand, B.; O’Neill, J.C.; Schwartz, R.; Nadkarni, M. Vitamin D deficiency in children with fractures. Pediatr. Emerg. Care 2014, 30, 777–781. [Google Scholar] [CrossRef] [PubMed]
- Gutierrez, O. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J. Am. Soc. Nephrol. 2005, 16, 2205–2215. [Google Scholar] [CrossRef] [PubMed]
- Rajasree, S.; Rajpal, K.; Kartha, C.C.; Sarma, P.S.; Kutty, V.R.; Iyer, C.S.P.; Girija, G. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur. J. Epidemiol. 2001, 17, 567–571. [Google Scholar] [CrossRef] [PubMed]
- Weber, K.T.; Simpson, R.U.; Carbone, L.D. Vitamin D and calcium dyshomeostasis-associated heart failure. Heart 2008, 94, 540–541. [Google Scholar] [CrossRef] [PubMed]
- Nibbelink, K.A.; Tishkoff, D.X.; Hershey, S.D.; Rahman, A.; Simpson, R.U. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J. Steroid Biochem. Mol. Biol. 2007, 103, 533–537. [Google Scholar] [CrossRef] [PubMed]
- Timms, P.M.; Mannan, N.; Hitman, G.A.; Noonan, K.; Mills, P.G.; Syndercombe-court, D.; Aganna, E.; Price, C.P.; Boucher, B.J. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM 2002, 95, 787–796. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.Y.; Lam, C.W.; Sanderson, J.E.; Wang, M.; Chan, I.H.; Lui, S.F.; Sea, M.M.; Woo, J. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: A 3-y prospective cohort study. Am. J. Clin. Nutr. 2008, 87, 1631–1638. [Google Scholar] [CrossRef] [PubMed]
- Zittermann, A.; Schleithoff, S.S.; Frisch, S.; Götting, C.; Kuhn, J.; Koertke, H.; Kleesiek, K.; Tenderich, G.; Koerfer, R. Circulating calcitriol concentrations and total mortality. Clin. Chem. 2009, 55, 1163–1170. [Google Scholar] [CrossRef] [PubMed]
- Melamed, M.L.; Michos, E.D.; Post, W.; Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 2008, 168, 1629–1637. [Google Scholar] [CrossRef] [PubMed]
- Melamed, M.L.; Muntner, P.; Michos, E.D.; Uribarri, J.; Weber, C.; Sharma, J.; Raggi, P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1179–1185. [Google Scholar] [CrossRef] [PubMed]
- Wang, T.J.; Pencina, M.J.; Booth, S.L.; Jacques, P.F.; Ingelsson, E.; Lanier, K.; Benjamin, E.J.; D’Agostino, R.B.; Wolf, M.; Vasan, R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117, 503–511. [Google Scholar] [CrossRef] [PubMed]
- Weishaar, R.E.; Kim, S.N.; Saunders, D.E.; Simpson, R.U. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am. J. Physiol. 1990, 258, E134–E142. [Google Scholar] [CrossRef] [PubMed]
- Weishaar, R.E.; Simpson, R.U. Vitamin D3 and cardiovascular function in rats. J. Clin. Investig. 1987, 79, 1706–1712. [Google Scholar] [CrossRef] [PubMed]
- Wang, A.Y.M.; Fang, F.; Chan, J.; Wen, Y.Y.; Qing, S.; Chan, I.H.S.; Lo, G.; Lai, K.N.; Lo, W.K.; Lam, C.W.K.; et al. Effect of paricalcitol on left ventricular mass and function in CKD—The OPERA trial. J. Am. Soc. Nephrol. 2014, 25, 175–186. [Google Scholar] [CrossRef] [PubMed]
- Bodyak, N.; Ayus, J.C.; Achinger, S.; Shivalingappa, V.; Ke, Q.; Chen, Y.S.; Rigor, D.L.; Stillman, I.; Tamez, H.; Kroeger, P.E.; et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc. Natl. Acad. Sci. USA 2007, 104, 16810–16815. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Przybylski, R.; McCune, S.; Hollis, B.; Simpson, R.U. Vitamin D deficiency in the spontaneously hypertensive heart failure (SHHF) prone rat. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 641–646. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Law, C.S.; Grigsby, C.L.; Olsen, K.; Hong, T.T.; Zhang, Y.; Yeghiazarians, Y.; Gardner, D.G. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 2011, 124, 1838–1847. [Google Scholar] [CrossRef] [PubMed]
- Wu, J.; Garami, M.; Cheng, T.; Gardner, D.G. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Investig. 1996, 97, 1577–1588. [Google Scholar] [CrossRef] [PubMed]
- Bae, S.; Yalamarti, B.; Ke, Q.; Choudhury, S.; Yu, H.; Karumanchi, S.A.; Kroeger, P.; Thadhani, R.; Kang, P.M. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc. Res. 2011, 91, 632–639. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, Y.C.; Kong, J.; Wei, M.; Chen, Z.F.; Liu, S.Q.; Cao, L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Investig. 2002, 110, 229–238. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.C. Vitamin D regulation of the renin-angiotensin system. J. Cell Biochem. 2003, 88, 327–331. [Google Scholar] [CrossRef] [PubMed]
- Xiang, W.; Kong, J.; Chen, S.; Cao, L.P.; Qiao, G.; Zheng, W.; Liu, W.; Li, X.; Gardner, D.G.; Li, Y.C. Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E125–E132. [Google Scholar] [CrossRef] [PubMed]
- Tishkoff, D.X.; Nibbelink, K.A.; Holmberg, K.H.; Dandu, L.; Simpson, R.U. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008, 149, 558–564. [Google Scholar] [CrossRef] [PubMed]
- Pilz, S.; Tomaschitz, A.; Drechsler, C.; Dekker, J.M.; März, W. Vitamin D deficiency and myocardial diseases. Mol. Nutr. Food Res. 2010, 54, 1103–1113. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.W.; Park, C.W.; Shin, Y.S.; Kim, Y.S.; Shin, S.J.; Kim, Y.S.; Choi, E.J.; Chang, Y.S.; Bang, B.K. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin. Pract. 2006, 102, c21–c29. [Google Scholar] [CrossRef] [PubMed]
- Yamshchikov, A.V.; Desai, N.S.; Blumberg, H.M.; Ziegler, T.R.; Tangpricha, V. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocr. Pract. 2009, 15, 438–449. [Google Scholar] [CrossRef] [PubMed]
- Goldsmith, D.J.A.; Covic, A.; Sambrook, P.A.; Ackrill, P. Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron 1997, 77, 37–43. [Google Scholar] [CrossRef] [PubMed]
- Milliner, D.S.; Zinsmeister, A.R.; Lieberman, E.; Landing, B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int. 1990, 38, 931–936. [Google Scholar] [CrossRef] [PubMed]
- Drüeke, T.B.; McCarron, D.A. Paricalcitol as compared with calcitriol in patients undergoing hemodialysis. N. Engl. J. Med. 2003, 349, 496–499. [Google Scholar] [CrossRef] [PubMed]
- Shoji, T.; Shinohara, K.; Kimoto, E.; Emoto, M.; Tahara, H.; Koyama, H.; Inaba, M.; Fukumoto, S.; Ishimura, E.; Miki, T.; et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol. Dial. Transplant. 2004, 19, 179–184. [Google Scholar] [CrossRef] [PubMed]
- Watson, K.E.; Abrolat, M.L.; Malone, L.L.; Hoeg, J.M.; Doherty, T.; Detrano, R.; Demer, L.L. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96, 1755–1760. [Google Scholar] [CrossRef] [PubMed]
- Teng, M.; Wolf, M.; Ofsthun, M.N.; Lazarus, J.M.; Hernán, M.A.; Camargo, C.A.; Thadhani, R. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J. Am. Soc. Nephrol. 2005, 16, 1115–1125. [Google Scholar] [CrossRef] [PubMed]
- Naves-Díaz, M.; Alvarez-Hernández, D.; Passlick-Deetjen, J.; Guinsburg, A.; Marelli, C.; Rodriguez-Puyol, D.; Cannata-Andía, J.B. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int. 2008, 74, 1070–1078. [Google Scholar] [CrossRef] [PubMed]
- Li, X.H.; Feng, L.; Yang, Z.H.; Liao, Y.H. The effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: A systematic review and meta-analysis. Nephrology 2015, 20, 706–714. [Google Scholar] [CrossRef] [PubMed]
- Teng, M.; Wolf, M.; Lowrie, E.; Ofsthun, N.; Lazarus, J.M.; Thadhani, R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N. Engl. J. Med. 2003, 349, 446–456. [Google Scholar] [CrossRef] [PubMed]
- Kalantar-Zadeh, K.; Kuwae, N.; Regidor, D.L.; Kovesdy, C.P.; Kilpatrick, R.D.; Shinaberger, C.S.; McAllister, C.J.; Budoff, M.J.; Salusky, I.B.; Kopple, J.D. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006, 70, 771–780. [Google Scholar] [CrossRef] [PubMed]
- Elstner, E.; Linker-Israeli, M.; Said, J.; Umiel, T.; de Vos, S.; Shintaku, I.P.; Heber, D.; Binderup, L.; Uskokovic, M.; Koeffler, H.P. 20-Epi-vitamin D3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res. 1995, 55, 2822–2830. [Google Scholar] [PubMed]
- Palmer, S.C.; McGregor, D.O.; Craig, J.C.; Elder, G.; Macaskill, P.; Strippoli, G.F. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database Syst. Rev. 2009, 4, CD005633. [Google Scholar] [CrossRef]
- Rammos, G.; Tseke, P.; Ziakka, S. Vitamin D, the renin-angiotensin system, and insulin resistance. Int. Urol. Nephrol. 2008, 40, 419–426. [Google Scholar] [CrossRef] [PubMed]
- Swedberg, K.; Eneroth, P.; Kjekshus, J.; Wilhelmsen, L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990, 82, 1730–1736. [Google Scholar] [CrossRef] [PubMed]
- Carthy, E.P.; Yamashita, W.; Hsu, A.; Ooi, B.S. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989, 13, 954–959. [Google Scholar] [CrossRef] [PubMed]
- Gysemans, C.A.; Cardozo, A.K.; Callewaert, H.; Giulietti, A.; Hulshagen, L.; Bouillon, R.; Eizirik, D.L.; Mathieu, C. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in non-obese diabetic mice. Endocrinology 2005, 146, 1956–1964. [Google Scholar] [CrossRef] [PubMed]
- Damås, J.K.; Gullestad, L.; Aass, H.; Simonsen, S.; Fjeld, J.G.; Wikeby, L.; Ueland, T.; Eiken, H.G.; Frøland, S.S.; Aukrust, P. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure—Modulatory effect of intravenous immunoglobulin. J. Am. Coll. Cardiol. 2001, 38, 187–193. [Google Scholar] [CrossRef]
- Cesselli, D.; Jakoniuk, I.; Barlucchi, L.; Beltrami, A.P.; Hintze, T.H.; Nadal-Ginard, B.; Kajstura, J.; Leri, A.; Anversa, P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 2001, 89, 279–286. [Google Scholar] [CrossRef] [PubMed]
- Ohsawa, M.; Koyama, T.; Yamamoto, K.; Hirosawa, S.; Kamei, S.; Kamiyama, R. 1,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000, 102, 2867–2872. [Google Scholar] [CrossRef] [PubMed]
- Simpson, R.U.; Hershey, S.H.; Nibbelink, K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J. Steroid Biochem. Mol. Biol. 2007, 103, 521–524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chiu, K.C.; Chu, A.; Go, V.L.; Saad, M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004, 79, 820–825. [Google Scholar] [CrossRef] [PubMed]
- Pittas, A.G.; Lau, J.; Hu, F.B.; Dawson-Hughes, B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92, 2017–2029. [Google Scholar] [CrossRef] [PubMed]
- Pilz, S.; Tomaschitz, A.; Ritz, E.; Pieberm, T.R. Vitamin D status and arterial hypertension: A systematic review. Nat. Rev. Cardiol. 2009, 6, 621–630. [Google Scholar] [CrossRef] [PubMed]
- Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2006, 83, 754–759. [Google Scholar] [CrossRef] [PubMed]
- Zittermann, A.; Schleithoff, S.S.; Tenderich, G.; Berthold, H.K.; Körfer, R.; Stehle, P. Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol. 2003, 41, 105–112. [Google Scholar] [CrossRef]
- Weishaar, R.E.; Simpson, R.U. The involvement of the endocrine system in regulating cardiovascular function: Emphasis on vitamin D3. Endocr. Rev. 1989, 10, 351–365. [Google Scholar] [CrossRef] [PubMed]
- Park, C.W.; Oh, Y.S.; Shin, Y.S.; Kim, C.M.; Kim, Y.S.; Kim, S.Y.; Choi, E.J.; Chang, Y.S.; Bang, B.K. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am. J. Kidney Dis. 1999, 33, 73–81. [Google Scholar] [CrossRef]
- O’Connell, T.D.; Berry, J.E.; Jarvis, A.K.; Somerman, M.J.; Simpson, R.U. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am. J. Physiol. 1997, 272, H1751–H1758. [Google Scholar] [CrossRef] [PubMed]
- De Boer, I.H.; Kestenbaum, B.; Shoben, A.B.; Michos, E.D.; Sarnak, M.J.; Siscovick, D.S. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 2009, 20, 1805–1812. [Google Scholar] [CrossRef] [PubMed]
- Green, J.J.; Robinson, D.A.; Wilson, G.E.; Simpson, R.U.; Westfall, M.V. Calcitriol modulation of cardiac contractile performance via protein kinase C. J. Mol. Cell. Cardiol. 2006, 41, 350–359. [Google Scholar] [CrossRef] [PubMed]
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 2017, 7, 1–59.
- Wolf, M.; Betancourt, J.; Chang, Y.; Shah, A.; Teng, M.; Tamez, H.; Gutierrez, O.; Camargo, C.A., Jr.; Melamed, M.; Norris, K.; et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J. Am. Soc. Nephrol. 2008, 19, 1379–1388. [Google Scholar] [CrossRef] [PubMed]
- Kovesdy, C.P.; Ahmadzadeh, S.; Anderson, J.E.; Kalantar-Zadeh, K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch. Intern. Med. 2008, 168, 397–403. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gluba-Brzózka, A.; Franczyk, B.; Ciałkowska-Rysz, A.; Olszewski, R.; Rysz, J. Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients. Nutrients 2018, 10, 709. https://doi.org/10.3390/nu10060709
Gluba-Brzózka A, Franczyk B, Ciałkowska-Rysz A, Olszewski R, Rysz J. Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients. Nutrients. 2018; 10(6):709. https://doi.org/10.3390/nu10060709
Chicago/Turabian StyleGluba-Brzózka, Anna, Beata Franczyk, Aleksandra Ciałkowska-Rysz, Robert Olszewski, and Jacek Rysz. 2018. "Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients" Nutrients 10, no. 6: 709. https://doi.org/10.3390/nu10060709
APA StyleGluba-Brzózka, A., Franczyk, B., Ciałkowska-Rysz, A., Olszewski, R., & Rysz, J. (2018). Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients. Nutrients, 10(6), 709. https://doi.org/10.3390/nu10060709